24-Hour Provoked Urine Excretion Test for Heavy Metals in Children with Autism and Typically Developing Controls, a Pilot Study

Introduction. The complementary and alternative medicine practice of prescribing chelators to children with autism is based on the premise that the chronic symptoms of autism can be ameliorated by reducing heavy metal body burden. However, there has not been definitive evidence, published to date, to support the assertion that children with autism are at increased risk of an excess chelatable body burden of heavy metals. The oral chelator meso-2,3-dimercaptosuccinic acid (DMSA) can be used diagnostically to mobilize heavy metals from extravascular pools, enhancing the identification of individuals who have a chelatable body burden. Methods. Seventeen children with autism and five typically developing children were enrolled in a pilot study to test for chelatable body burden of Arsenic (As), Cadmium (Cd), Lead (Pb), and Mercury (Hg). Evaluation included a questionnaire regarding potential exposure to heavy metals, diet restrictions, a baseline 24-hour urine collection, and a DMSA-provoked urine collection. Urine collections were sent for As, Cd, Pb, and Hg quantification by Inductively Coupled Plasma-Mass Spectrometry. Unprovoked reference ranges were used in the interpretation of all collections. Results. Fifteen autistic children and four typically developing children completed the study. Three autistic subjects excreted one metal in greater quantity during the provoked excretion than baseline. Two of these were very close to the limit of detection. In the third case, the provoked excretion of mercury was between the upper limit of normal and lower limit of the potentially toxic reference range. Fish was removed from this child's diet for greater than one month, and the provoked excretion test repeated. The repeat excretion of mercury was within the normal range. Conclusion. In the absence a proven novel mode of heavy metal toxicity, the proportion of autistic participants in this study whose DMSA provoked excretion results demonstrate an excess chelatable body burden of As, Cd, Pb, or Hg is zero. The confidence interval for this proportion is 0–22%.

[1]  U. Taitelman,et al.  Meso-2,3-dimercaptosuccinic acid in the diagnosis and treatment of lead poisoning. , 1987, Journal of toxicology. Clinical toxicology.

[2]  L. W. Welch,et al.  Elemental Mercury Vapour Toxicity, Treatment, and Prognosis After Acute, Intensive Exposure in Chloralkali Plant Workers. Part I: History, Neuropsychological Findings and Chelator effects , 1992, Human & experimental toxicology.

[3]  E. Cook,et al.  Genetics of autism. , 2001, Child and adolescent psychiatric clinics of North America.

[4]  R. Byers,et al.  Edathamil calcium-disodium (versenate) in treatment of lead poisoning in children. , 1954, A.M.A. American journal of diseases of children.

[5]  H. Aposhian,et al.  meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent. , 1990, Annual review of pharmacology and toxicology.

[6]  V. Hertzberg,et al.  Diagnostic chelation challenge with DMSA: a biomarker of long-term mercury exposure? , 2001, Environmental health perspectives.

[7]  K. Hurlbut,et al.  Mobilization of heavy metals by newer, therapeutically useful chelating agents. , 1995, Toxicology.

[8]  P J Landrigan,et al.  A cluster of pediatric metallic mercury exposure cases treated with meso-2,3-dimercaptosuccinic acid (DMSA) , 2000, Environmental health perspectives.

[9]  L. Garza-Ocañas,et al.  Urinary mercury in twelve cases of cutaneous mercurous chloride (calomel) exposure: effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy. , 1997, Journal of toxicology. Clinical toxicology.

[10]  A. Bailey,et al.  Autism as a strongly genetic disorder: evidence from a British twin study , 1995, Psychological Medicine.

[11]  L. Magos THE EFFECTS OF DIMERCAPTOSUCCINIC ACID ON THE EXCRETION AND DISTRIBUTION OF MERCURY IN RATS AND MICE TREATED WITH MERCURIC CHLORIDE AND METHYLMERCURY CHLORIDE , 1976, British journal of pharmacology.

[12]  W. Stewart,et al.  Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites. , 1995, Occupational and environmental medicine.

[13]  H. Roels,et al.  Urinary excretion of mercury after occupational exposure to mercury vapour and influence of the chelating agent meso-2,3-dimercaptosuccinic acid (DMSA). , 1991, British journal of industrial medicine.